Skip to main content

Catalyst OrthoScience Surpasses 10,000 Total Shoulder Arthroplasty (TSA) Procedures and Announces $20 Million Financing

By Press Release
NAPLES, Fla., – Catalyst OrthoScience Inc. (“Catalyst”), a private medical technology leader focused on shoulder arthroplasty, the fastest growing segment in the orthopedics market, announces it has surpassed 10,000 total shoulder arthroplasty (TSA) procedures as it closes $20 million in equity and venture debt financing with funding partners RC Capital,…
Read More

Orthopedics Corner: Catalyst Looks To Clinical Data To Distinguish Its Shoulder Arthroplasty Technology

By In The News
Catalyst OrthoScience is counting on clinical research to show that its stemless shoulder arthroplasty system promotes faster healing and the restoration of a patient’s normal range of motion. Shoulder arthroplasty technology has not changed much since Charles Neer first developed total shoulder implants in the 1950s and 1960s,  Matthew Budge, an orthopedic surgeon…
Read More

Catalyst OrthoScience Announces Mark Quick as Chief Financial Officer

By Press Release
NAPLES, Fla.--(BUSINESS WIRE)--Catalyst OrthoScience Inc. (Catalyst), a medical device company focused on the upper extremity orthopedics market, has appointed seasoned medical device leader Mark Quick as chief financial officer of the organization, effective immediately. Quick joins Catalyst with nearly two decades of medical device experience. He was most recently at Orthofix Medical Inc.…
Read More

Catalyst OrthoScience Announces First Series of Procedures Using World’s Only Fully Convertible Stemmed CSR TSA System Featuring an Ellipsoid Humeral Head

By Press Release
Internationally known shoulder surgeon Theodore Blaine, MD, performed first series of procedures Theodore Blaine, MD, has completed the first series of total shoulder arthroplasty procedures using the Catalyst Stemmed CSR TSA fully convertible system with an ellipsoid humeral head. (Photo: Business Wire) NAPLES, Fla.--(BUSINESS WIRE)--Catalyst OrthoScience Inc. (Catalyst), a medical device…
Read More

Catalyst Receives FDA 510(k) Clearance for its Convertible Stemmed Total Shoulder Arthroplasty System

By Press Release
Catalyst OrthoScience Inc. (Catalyst), a medical device company focused on the upper extremity orthopedics market, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its fully convertible stemmed total shoulder arthroplasty system with an ellipsoid anatomic head. This is the market’s first stemmed arthroplasty system featuring…
Read More

Hurricane Ian Update

By In The News
Updated on Monday, October 3: Power has been restored to all Southwest Florida Catalyst facilities and our offices reopened today. Our Customer Service department is processing orders and our Distribution Center continues to fulfill orders and customer needs from our back-up location in Southeast Florida to ensure that any shipments…
Read More

Catalyst OrthoScience Features Innovative Products And Shoulder Surgery Leaders At AAOS

By Press Release
Visit booth #2408 for product demonstrations of the Archer™ Shoulder Systems NAPLES, Fla., March 22, 2022 – Catalyst OrthoScience Inc. (Catalyst), a medical device company focused on the upper extremity orthopedics market, will be at the American Academy of Orthopedic Surgeons (AAOS) 2022 Annual Meeting, March 23-25, 2022, in Chicago. At booth #2408,…
Read More